Status:
COMPLETED
Effect of ESPB on Postoperative Pain in Patients With Breast Cancer Implant Reconstruction
Lead Sponsor:
Fudan University
Conditions:
Mammary Cancer
Erector Spinae Plane Block
Eligibility:
FEMALE
18-70 years
Phase:
NA
Brief Summary
Nowadays, the incidence of breast cancer is the first number of malignant tumors, and the primary treatment method is surgery.With the development of medical technology and concept, radical mastectomy...
Detailed Description
Patients: 100 breast cancer patients who are planned radical mastectomy combined breast reconstruction Intervention: General anesthesia + erector spinae plane block Control ： General anesthesia Outcom...
Eligibility Criteria
Inclusion
- patients scheduled for an radical mastectomy and implant reconstruction surgery
- Patients with American Society of Anesthesiologists (ASA) physical status I-II,
- aged 18-70 years
Exclusion
- coagulation disorders,
- known allergy to study drugs,
- obesity (body mass index \> 35 kg/m2),
- infection at the injection site,
- chronic opioid consumption, and an inability to use patient-controlled analgesia (PCA) device,
- patient refuse
Key Trial Info
Start Date :
November 20 2023
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 25 2025
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT06143020
Start Date
November 20 2023
End Date
August 25 2025
Last Update
November 17 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Fudan University Shanghai Cancer Center
Shanghai, Shanghai Municipality, China, 200032